SIMPONI® Resources | SIMPONI® (golimumab)

Access Options for your SIMPONI® patients

SIMPONI® has access for the majority of patients

  • SIMPONI® is available as a first-line biologic for nearly 80 million commercial patients1

What Janssen CarePath can do for you on behalf of your patients:

  • Conduct benefits investigations and provide insurance coverage information
  • Give you support with a dedicated Care Coordinator for you and your patients
  • Deliver 24-hour access to request and review benefits investigations through our online provider portal
  • Provide online resource to help your eligible patients enroll in Savings Program

Reference: 1. Data on file. Janssen Biotech, Inc.


You prescribe SIMPONI®. Janssen Link will make the connection

  • The Janssen Link program provides SIMPONI® at no cost if commercial insurance delays (>5 business days) or denies access to treatment
  • This program is not available to individuals who use any state or federal government-subsidized healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE®, Department of Defense, Veterans Administration or any other federal or state healthcare plan, including pharmaceutical assistance programs